Avion Wealth Biomarin Pharmaceutical Inc Transaction History

Avion Wealth

$389 Million
Q4 2024

A detailed history of Avion Wealth transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Avion Wealth holds 26 shares of BMRN stock, worth $1,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 41 36.59%

Holding current value

$1,623

Previous $2,000 50.0%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$61.93 - $70.49 $928 - $1,057	-15 Reduced 36.59%	26 $1,000
Q3 2024 Oct 18, 2024	BUY	$69.02 - $93.84 $1,932 - $2,627	28 Added 215.38%	41 $2,000
Q2 2024 Jul 26, 2024	SELL	$74.43 - $92.22 $372 - $461	-5 Reduced 27.78%	13 $1,000
Q1 2024 May 03, 2024	SELL	$83.81 - $99.0 $419 - $495	-5 Reduced 21.74%	18 $2,000
Q4 2023 Jan 26, 2024	BUY	$76.22 - $98.51 $1,295 - $1,674	17 Added 283.33%	23 $2,000
Q3 2023 Oct 20, 2023	SELL	$85.07 - $94.48 $340 - $377	-4 Reduced 40.0%	6 $0
Q2 2023 Jul 14, 2023	BUY	$86.68 - $100.3 $866 - $1,003	10 New	10 $0

Others Institutions Holding BMRN

# of Institutions

645

Shares Held

178M

Call Options Held

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.6B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.

Account